health - "cancer"

Apparently 'normal' cells may carry cancer to new sites long before a tumour develops, scientists say.

U.S. drug regulators said this week that they were investigating whether the cholesterol-lowering drug Vytorin might be linked to cancer.

Pro-Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of Davanat in combination with 5-FU to treat a breast cancer patient at the Brown cancer Center in Louisville, Kentucky. Davanat also is being administered in Phase II clinical trials for first-line treatment of colorectal and biliary cancer patients.

Young women who experience more than one stressful life event are at greater risk of developing breast cancer, but a general feeling of happiness and optimism may help guard against the disease, Israeli researchers report.

Recent advances in cervical cancer prevention offer new hope for controlling the disease in developing countries, where 80% of cases occur.

Medicare overpaid for irinotecan, a cancer drug sold by Pfizer under the name Campostar, by $6.5 million in March because of a delay in updating its pricing formula, according to a report released on Tuesday by the HHS Office of Inspector General, Bloomberg/Los Angeles Times reports.read more

CHICAGO (AP) -- In an Aug. 26 story about a new TV ad linking hot dogs with cancer, The Associated Press, relying on figures provided by a nutrition adviser to the American Institute for cancer Research, erroneously reported average risks for colon cancer and how eating hot dogs affects those risks. Karen Collins said she misstated the average adult's lifetime risk for getting colorectal cancer, which is about 5 percent, not 5.8 percent....

Recent advances in cervical cancer prevention mean that controlling the disease in developing countries is becoming feasible for the first time, experts say.

A baby's photo posted in an online forum reveals the presence of retinoblastoma.

The clinical laboratory company LabCorp is offering a new blood test aimed at detecting ovarian cancer at an early and still treatable stage, but the test is being met with concern among many physicians and medical organizations, the New York Times reports.